113225-18-6

Basic information

• Product Name: 3-PIPERIDINOL, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-, CIS-(+)-
• Synonyms: 3-PIPERIDINOL, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-, CIS-(+)-
• CAS NO: 113225-18-6
• Molecular Formula: C₁₅H₂₃NO₄
• Molecular Weight: 281.35
• Mol File: 113225-18-6.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 406.5±45.0 °C(Predicted)
• Appearance: /
• Density: 1.122±0.06 g/cm3(Predicted)
• PKA: 14.55±0.40(Predicted)
• CAS DataBase Reference: 3-PIPERIDINOL, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-, CIS-(+)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-PIPERIDINOL, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-, CIS-(+)-(113225-18-6)
• EPA Substance Registry System: 3-PIPERIDINOL, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-, CIS-(+)-(113225-18-6)

Safety Data

• Hazardous Substances Data: 113225-18-6(Hazardous Substances Data)

Upstream product

• 113225-10-8 (+)-1-Methyl-4-(2,4,6-trimethoxyphenyl)-piperidin-3-one 
• 113225-08-4 (±)-trans-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-ol 
• 113225-07-3 1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydropyridine 
• 621-23-8 1,2,3-trimethoxybenzene 
• 1445-73-4 1-Methyl-4-piperidone 

Downstream Products

• 113225-08-4 cis-1-methyl-4-(2,4,6-trimethoxyphenyl)-3-piperidinol 
• 71294-60-5 (+)-cisa-5,7-dihydroxy-methyl-8-<4-(3-hydroxy-1-methyl)piperidinyl>-4H-1-benzopyran-4-one 
• 920112-97-6 (-)-trans-[1-methyl-3-(2,4,6-trimethoxyphenyl)pyrrolidin-2-yl]methanol 
• 1000023-98-2 [1-methyl-3-(2,4,6-trimethoxyphenyl)pyrrolidin-2-yl]methanol 
• 920112-99-8 ((-)-trans-acetic acid-3-(3-acetyl-2-hydroxy-4,6-dimethoxyphenyl)-1-methylpyrrolidin-2-yl)methyl ester 
• 1622998-49-5 (-)-trans-2-(2-(acetoxymethyl)-1-methylpyrrolidin-3-yl)-6-acetyl-3,5-dimethoxyphenyl-2-chlorobenzoate 
• 920113-01-5 (+)-trans-2-(2-chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one 
• 920113-02-6 (+)-trans-2-(2-chloro-phenyl)-5,7-dihydroxy-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-chromen-4-one 
• 920113-03-7 (+)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]-4H-chromen-4-one hydrochloride 
• 1254504-57-8 C₁₅H₂₃NO₄*C₁₈H₁₄O₈ 
• 1623001-48-8 C₁₅H₂₃NO₄*C₁₈H₁₄O₈ 
• 113225-14-2 (-)-cis-4-(3-acetyl-4,6-dimethoxy-2-hydroxy)phenyl-1-methyl-3-piperidinol 

Relevant articles and documents

PYRROLIDINE-SUBSTITUTED FLAVONES AS RADIO-SENSITIZERS FOR USE IN THE TREATMENT OF CANCER

The present invention relates to a combination for the treatment of cancer wherein the combination exhibits a synergistic effect. The combination comprises radiation and at least one cyclin dependent kinase (CDK) inhibitor selected from the compounds of f

A PROCESS FOR PREPARATION OF AN INTERMEDIATE OF THE PYRROLIDINE SUBSTITUTED FLAVONES

The present invention relates to a process for the preparation of a key intermediate (as described herein) used in the synthesis of (+)-trans enantiomer of pyrrolidine substituted flavones, represented by the compounds of formula (1) or pharmaceutically a

NOVEL ENANTIOMERICALLY PURE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS

The present invention relates to an enantiomerically pure (+)-trans-enantiomer of a compound represented by the following formula (I): wherein R1, R2, R3, R4 and R9 are as defined in the specification; enantiomerically pure intermediates thereof, to processes for the preparation of the enantiomerically pure compound and its intermediates, and to a pharmaceutical composition comprising the enantiomerically pure compound. The compound of formula (I) is useful for the treatment of diseases or disorders mediated by the inhibition of cyclin dependant kinase, such as cancer.